Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Department of Hepatobiliary and Pancreatic Surgery, Guangshan County People's Hospital, Xinyang, China.
Front Immunol. 2021 Nov 10;12:674074. doi: 10.3389/fimmu.2021.674074. eCollection 2021.
As a new infectious disease, COVID-19 is spread through the respiratory tract in most cases. Its source and pathological mechanism are not clear. The most common clinical feature is pulmonary infection. Also, a lot patients have gastrointestinal symptoms. Angiotensin-converting enzyme 2 (ACE2) is a functional cellular receptor for SARS-CoV-2, which is like SARS-CoV, a coronavirus associated with severe acute respiratory syndrome (SARS) outbreak in 2003. The tissues and cells expressing ACE2 are potential targets for SARS-CoV-2 infection, and the high expression of ACE2 in intestinal epithelial cells marks that SARS-CoV-2 may directly infect intestinal epithelial cells. Recent studies also suggest that SARS-CoV-2 existed and replicated in intestinal environment for a long time. The interaction between SARS-CoV-2 and RAS system leads to the decrease of local anti-inflammatory ability. The virus cycle leads to excessive imbalance of immune response and cytokine release. The downregulation of ACE2 after viral infection leads to gastrointestinal dysfunction. The above are the causes of gastrointestinal symptoms. Here, we reviewed the possible causes and mechanisms of gastrointestinal symptoms caused by COVID-19. Additionally, we discussed the influence of gastrointestinal symptoms on the prognosis of patients.
作为一种新发传染病,COVID-19 多数通过呼吸道传播。其病因和发病机制尚不清楚,最常见的临床特征是肺部感染,同时很多患者伴有胃肠道症状。血管紧张素转换酶 2(ACE2)是 SARS-CoV-2 的功能性细胞受体,与 2003 年严重急性呼吸综合征(SARS)爆发相关的冠状病毒 SARS-CoV 类似。表达 ACE2 的组织和细胞是 SARS-CoV-2 感染的潜在靶标,而 ACE2 在肠上皮细胞中的高表达标志着 SARS-CoV-2 可能直接感染肠上皮细胞。最近的研究还表明,SARS-CoV-2 在肠道环境中存在并复制了很长时间。SARS-CoV-2 与 RAS 系统的相互作用导致局部抗炎能力下降,病毒周期导致免疫反应和细胞因子释放过度失衡,病毒感染后 ACE2 的下调导致胃肠功能障碍。以上是引起胃肠道症状的原因。在这里,我们综述了 COVID-19 引起胃肠道症状的可能原因和机制,并讨论了胃肠道症状对患者预后的影响。